These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3302400)

  • 41. Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome.
    Pixley RA; Zellis S; Bankes P; DeLa Cadena RA; Page JD; Scott CF; Kappelmayer J; Wyshock EG; Kelly JJ; Colman RW
    Crit Care Med; 1995 Jan; 23(1):41-51. PubMed ID: 7528118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Removal of IgG from normal plasma and plasma from untreated patients with active Crohn's disease--effect on levels of contact factors.
    Briseid K; Lygren I; Johannesen S; Marthinsen K
    Scand J Clin Lab Invest; 2000 May; 60(3):237-45. PubMed ID: 10885496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A study of coagulation contact factors in hereditary angioneurotic oedema (author's transl)].
    Soulier JP; Gozin D; Ollier-Hartmann MP; Hartmann L
    Nouv Presse Med; 1981 May; 10(20):1627-31. PubMed ID: 6166918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A pre-albumin activator of prekallikrein.
    Kaplan AP; Austen KF
    J Immunol; 1970 Oct; 105(4):802-11. PubMed ID: 5470521
    [No Abstract]   [Full Text] [Related]  

  • 46. Differences in prekallikrein and high molecular weight kininogen levels in two strains of Brown Norway rat (Kitasato strain and Katholiek strain).
    Oh-ishi S; Satoh K; Hayashi I; Yamazaki K; Nakano T
    Thromb Res; 1982 Oct; 28(1):143-7. PubMed ID: 6925403
    [No Abstract]   [Full Text] [Related]  

  • 47. [Studies on contact factors. I. A method for the measurement of "content activity" with artifically depleted normal plasma].
    Umeda T
    Nihon Ketsueki Gakkai Zasshi; 1968 Dec; 31(7):1165-72. PubMed ID: 5753797
    [No Abstract]   [Full Text] [Related]  

  • 48. The contact phase of blood coagulation and renin activation in essential hypertension before and after captopril.
    Patrassi GM; Fallo F; Martinelli S; Mantero F; Boeri G; Girolami A
    Eur Heart J; 1984 Jul; 5(7):561-7. PubMed ID: 6383834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma prekallikrein activity in patients with total hip arthroplasty.
    Hoffmann JJ; Kortmann JH
    Thromb Haemost; 1987 Dec; 58(4):1040-2. PubMed ID: 3445224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A quarter century with Mr. Hageman.
    Ratnoff OD
    Thromb Haemost; 1980 Jun; 43(2):95-8. PubMed ID: 7006141
    [No Abstract]   [Full Text] [Related]  

  • 51. [Role of the contact plasma system in human physiopathology].
    Sánchez-Ibarrola A; Villaro J; Subirá ML
    Rev Esp Fisiol; 1989; 45 Suppl():233-8. PubMed ID: 2701761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prekallikrein deficiency in a dog.
    Chinn DR; Dodds WJ; Selcer BA
    J Am Vet Med Assoc; 1986 Jan; 188(1):69-71. PubMed ID: 3632973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical and experimental studies on the contact factor. I. Contact factor activity in various dieases].
    Ito M
    Nihon Ketsueki Gakkai Zasshi; 1968 Dec; 31(7):1142-54. PubMed ID: 5753795
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on some coagulation factors (Hageman factor, plasma prekallikrein, and high molecular weight kininogen) in the normal newborn.
    Gordon EM; Ratnoff OD; Saito H; Gross S; Jones PK
    Am J Pediatr Hematol Oncol; 1980; 2(3):213-6. PubMed ID: 7435882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Defective esterase and kinin-forming activity in human Fletcher trait plasma. A fraction rich in kallikreinlike activity.
    Donaldson VH; Saito H; Ratnoff OD
    Circ Res; 1974 May; 34(5):652-62. PubMed ID: 4545268
    [No Abstract]   [Full Text] [Related]  

  • 56. A study of hemostasis in ischemic cerebrovascular disease: IV. A five year follow-up of some blood coagulation parameters also including fibrinopeptide A, factor XII and prekallikrein.
    Mettinger KL
    Thromb Res; 1982 Jul; 27(2):155-60. PubMed ID: 6814002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prothromboplastin factor group (factors VIII, IX, XI, XII)--interpretation of the test results].
    Kagami M
    Nihon Rinsho; 1973; 31():1721-33. PubMed ID: 4795303
    [No Abstract]   [Full Text] [Related]  

  • 58. Kinin activation as a predictive assay for adverse reactions to radiographic contrast medium.
    Carr DH; Walker AC
    Acta Radiol Diagn (Stockh); 1984; 25(4):337-42. PubMed ID: 6567445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acetylcysteine in rats: inhibition of activation of prekallikrein and factor XII--protection against dextran-induced blood pressure fall.
    Hoem NO; Briseid G
    Pharmacol Toxicol; 1987 Feb; 60(2):140-4. PubMed ID: 2437551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prekallikrein deficiency in a family of miniature horses.
    Turrentine MA; Sculley PW; Green EM; Johnson GS
    Am J Vet Res; 1986 Nov; 47(11):2464-7. PubMed ID: 3641551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.